Awadalla, A.; Hussein, A.M.; El-Far, Y.M.; El-Senduny, F.F.; Barakat, N.; Hamam, E.T.; Abdeen, H.M.; El-Sherbiny, M.; Serria, M.S.; Sarhan, A.A.;
et al. Rapamycin Improves Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Renoprotective Effect against Cisplatin-Induced Acute Nephrotoxicity in Rats by Inhibiting the mTOR/AKT Signaling Pathway. Biomedicines 2022, 10, 1295.
https://doi.org/10.3390/biomedicines10061295
AMA Style
Awadalla A, Hussein AM, El-Far YM, El-Senduny FF, Barakat N, Hamam ET, Abdeen HM, El-Sherbiny M, Serria MS, Sarhan AA,
et al. Rapamycin Improves Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Renoprotective Effect against Cisplatin-Induced Acute Nephrotoxicity in Rats by Inhibiting the mTOR/AKT Signaling Pathway. Biomedicines. 2022; 10(6):1295.
https://doi.org/10.3390/biomedicines10061295
Chicago/Turabian Style
Awadalla, Amira, Abdelaziz M. Hussein, Yousra M. El-Far, Fardous F. El-Senduny, Nashwa Barakat, Eman T. Hamam, Hanaa M. Abdeen, Mohamed El-Sherbiny, Mohamed S. Serria, Amira A. Sarhan,
and et al. 2022. "Rapamycin Improves Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Renoprotective Effect against Cisplatin-Induced Acute Nephrotoxicity in Rats by Inhibiting the mTOR/AKT Signaling Pathway" Biomedicines 10, no. 6: 1295.
https://doi.org/10.3390/biomedicines10061295
APA Style
Awadalla, A., Hussein, A. M., El-Far, Y. M., El-Senduny, F. F., Barakat, N., Hamam, E. T., Abdeen, H. M., El-Sherbiny, M., Serria, M. S., Sarhan, A. A., Sena, A. M., & Shokeir, A. A.
(2022). Rapamycin Improves Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Renoprotective Effect against Cisplatin-Induced Acute Nephrotoxicity in Rats by Inhibiting the mTOR/AKT Signaling Pathway. Biomedicines, 10(6), 1295.
https://doi.org/10.3390/biomedicines10061295
